We employed targeted next-generation sequencing to analyze seven actionable driver genes - EGFR, KRAS, NRAS, BRAF, ALK, ROS1, and PIK3CA - in formalin-fixed, paraffin-embedded tumor specimens from Vietnamese NSCLC patients. This evidence concerns the gene KRAS and neoplasm.